Prospective, Post Marketing Surveillance of RECTABUL2mg rectal form
Not Applicable
Completed
- Conditions
- lcerative colitis (except for severe disease)
- Registration Number
- JPRN-jRCT1080223802
- Lead Sponsor
- EA Pharma Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Ulcerative colitis patients
Exclusion Criteria
Off-label use
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>Partial Mayo Score<br>Evaluate the difference in measurement before and after administration
- Secondary Outcome Measures
Name Time Method efficacy<br>Mayo sub-score, VAS, Laboratory test value<br>Evaluate the difference in measurement before and after administration